Related Experiment Video
Updated: May 14, 2026
07:27
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Long-term prognosis in community-acquired pneumonia
Marcos I Restrepo1, Paola Faverio, Antonio Anzueto
1University of Texas Health Science Center at San Antonio, Texas, USA.
Current Opinion in Infectious Diseases
|February 22, 2013
Summary
Community-acquired pneumonia (CAP) significantly impacts long-term mortality, with risk factors like age and comorbidities increasing death rates. Further research and public health initiatives are crucial to address this persistent challenge in CAP patient care.
Area of Science:
- Infectious Diseases
- Public Health
- Critical Care Medicine
Background:
- Community-acquired pneumonia (CAP) is a leading cause of infectious disease death in the US.
- Understanding CAP's impact on patient mortality is of significant interest.
- Short-term mortality endpoints (in-hospital, 30-day) are commonly used in clinical studies.
Purpose of the Study:
- To review recent literature on long-term mortality in CAP patients.
- To assess the frequency, risk factors, and implications of long-term outcomes.
- To identify potential future strategies for managing CAP-related mortality.
Main Methods:
- Literature review of recent studies on community-acquired pneumonia.
- Analysis of factors influencing long-term mortality (>3 months) post-CAP.
- Examination of risk factors and biomarkers associated with mortality.
Main Results:
- Multiple risk factors, including age, sex, comorbidities, pneumonia type, and severity, are linked to higher long-term mortality.
- Biomarkers have been identified as independent predictors of long-term mortality in CAP patients.
- Current clinical studies often overlook long-term mortality in favor of short-term endpoints.
Conclusions:
- A high and unacceptable rate of long-term mortality persists among CAP patients.
- Existing public health programs need to address this gap in care.
- The complexity of factors influencing CAP outcomes requires comprehensive strategies.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.